Mayinglong Pharmaceutical Group Co Ltd (600993) — Net Asset Momentum
Mayinglong Pharmaceutical Group Co Ltd (600993) recorded a net asset momentum of 7.5% as of December 2025, with net assets of CN¥4.51 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check 600993 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Mayinglong Pharmaceutical Group Co Ltd Net Asset Momentum (2001–2025)
This chart tracks Mayinglong Pharmaceutical Group Co Ltd's year-over-year net asset growth across 25 annual reporting periods from 2001 to 2025. The most recent momentum reading is +7.5%, with net assets of CN¥4.51 Billion CNY as of December 2025. Read 600993 total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Mayinglong Pharmaceutical Group Co Ltd (2001–2025)
The table below shows the complete annual net asset history for Mayinglong Pharmaceutical Group Co Ltd from 2001 to 2025, covering 25 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 600993 market cap overview.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥4.51 Billion | CN¥5.44 Billion | CN¥921.49 Million | ▲ +7.5% |
| 2024 | CN¥4.20 Billion | CN¥5.18 Billion | CN¥980.66 Million | ▲ +8.6% |
| 2023 | CN¥3.87 Billion | CN¥4.83 Billion | CN¥959.62 Million | ▲ +6.9% |
| 2022 | CN¥3.62 Billion | CN¥5.06 Billion | CN¥1.44 Billion | ▲ +9.2% |
| 2021 | CN¥3.31 Billion | CN¥4.13 Billion | CN¥812.72 Million | ▲ +12.5% |
| 2020 | CN¥2.95 Billion | CN¥3.87 Billion | CN¥919.89 Million | ▲ +11.8% |
| 2019 | CN¥2.63 Billion | CN¥3.29 Billion | CN¥650.49 Million | ▲ +12.0% |
| 2018 | CN¥2.35 Billion | CN¥2.93 Billion | CN¥574.67 Million | ▲ +3.6% |
| 2017 | CN¥2.27 Billion | CN¥2.75 Billion | CN¥482.99 Million | ▲ +12.6% |
| 2016 | CN¥2.02 Billion | CN¥2.50 Billion | CN¥479.88 Million | ▲ +6.9% |
| 2015 | CN¥1.89 Billion | CN¥2.41 Billion | CN¥523.31 Million | ▲ +11.1% |
| 2014 | CN¥1.70 Billion | CN¥2.19 Billion | CN¥486.89 Million | ▲ +8.5% |
| 2013 | CN¥1.57 Billion | CN¥2.03 Billion | CN¥461.22 Million | ▲ +9.3% |
| 2012 | CN¥1.43 Billion | CN¥1.84 Billion | CN¥409.56 Million | ▲ +8.6% |
| 2011 | CN¥1.32 Billion | CN¥1.66 Billion | CN¥337.70 Million | ▲ +17.1% |
| 2010 | CN¥1.13 Billion | CN¥1.45 Billion | CN¥321.68 Million | ▲ +7.2% |
| 2009 | CN¥1.05 Billion | CN¥1.44 Billion | CN¥384.11 Million | ▲ +20.7% |
| 2008 | CN¥871.43 Million | CN¥1.16 Billion | CN¥291.46 Million | ▲ +2.1% |
| 2007 | CN¥853.12 Million | CN¥1.09 Billion | CN¥238.53 Million | ▼ -0.2% |
| 2006 | CN¥855.21 Million | CN¥1.11 Billion | CN¥250.53 Million | ▲ +43.4% |
| 2005 | CN¥596.55 Million | CN¥772.00 Million | CN¥175.45 Million | ▲ +8.0% |
| 2004 | CN¥552.20 Million | CN¥682.94 Million | CN¥130.74 Million | ▲ +138.7% |
| 2003 | CN¥231.35 Million | CN¥367.95 Million | CN¥136.61 Million | ▲ +13.1% |
| 2002 | CN¥204.54 Million | CN¥363.13 Million | CN¥158.59 Million | ▲ +18.9% |
| 2001 | CN¥172.01 Million | CN¥320.89 Million | CN¥148.88 Million | — |